Cross-species costimulation: Relative contributions of CD80, CD86, and CD40

Transplantation

Volumn 75, Issue 12, 2003, Pages 2068-2076

  Rogers, Nicola J ^a   Jackson, Ian M ^a   Jordan, William J ^a   Hawadle, Muhamed A ^a   Dorling, Anthony ^a   Lechler, Robert I ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; HLA ANTIGEN; HLA DR1 ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE REACTION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; SWINE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; XENOGRAFT; XENOGRAFT RECOGNITION; XENOTRANSPLANTATION;

EID: 0037774763     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000069100.67646.08     Document Type: Article

References (26)

1. Rogers NJ, Mirenda V, Jackson I, et al. Costimulatory blockade by the induction of an endogenous xenospecific antibody response. Nat Immunol 2000; 1: 163.
2. Dorling A, Lombardi G, Binns R, et al. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol 1996; 26(6): 1378.
3. Dorling A, Binns R, Lechler RI. Cellular xenoresponses: observation of significant primary indirect human T cell anti-pig xenoresponses using co-stimulator-deficient or SLA class II-negative porcine stimulators. Xenotransplantation 1996; 3: 112.
4. Kirk AD, Li RA, Kinch MS, et al. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation 1993; 55(4): 924.
5. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995; 155(11): 5249.
6. Kumagai-Braesch M, Johansson Borg A, Satake M, et al. Characteristics of direct and indirect activation of human T cells against allogeneic and porcine xenogeneic cells/peptides. Xenotransplantation 1997; 4: 85.
7. Alter BJ, Bach FH. Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J Exp Med 1990; 171(1): 333.
8. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A 1992; 89(22): 11102.
9. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178(5): 1801.
10. Baliga P, Chavin KD, Qin L, et al. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 1994; 58(10): 1082.
11. Lenschow DJ, Zeng Y, Hathcock KS, et al. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60(10): 1171.
12. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997; 64(12): 1838.
13. Lu L, Li W, Fu F, et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64(12): 1808.
14. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61(1): 4.
15. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381(6581): 434.
16. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig [see comments]. Science 1992; 257(5071): 789.
17. Tran HM, Nickerson PW, Patel A, et al. Short-term xenosuppression of the xeno immune response with mCTLA4Fc treatment. Xenotransplantation 1997; 4: 222.
18. Larsen CP, Pearson TC. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 1997; 9(5): 641.
19. Maher SE, Karmann K, Min W, et al. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing, and functional expression in human endothelial cells. J Immunol 1996; 157(9): 3838.
20. Faas SJ, Giannoni MA, Mickle AP, et al. Primary structure and functional characteristics of a soluble, alternatively spliced form of B7-1. J Immunol 2000; 164(12): 6340.
21. West KA, Li A, Al-Alwan MM, et al. Cloning of the porcine costimulatory molecule CD40. Transplant Proc 1999; 31: 928.
22. Hargreaves R, Logiou V, Lechler R. The primary alloresponse of human CD4+ T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression. Int Immunol 1995; 7(9): 1505.
23. Vaughan A, Malde P, Rogers NJ, et al. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4 T cell responses costimulated by pig but not human B7. J Immunol 2000; 165: 3175.
24. Jordan WJ, Ritter MA. Optimal analysis of composite cytokine responses during alloreactivity. J Immunol Methods 2002; 260: 1.
25. Lee RS, Yamada K, Womer KL, et al. Blockade of B7-CD28, but not CD40-CD40L, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses. J Immunol 2000; 164: 3434.
26. Popma SH, Kransinskas AM, Kriesel D, et al. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T cell response. Transplant Proc 2001; 33(1-2): 767.